Potomac, MD, United States of America

Nava Sarver

This inventor holds 1 USPTO granted patent. Top assignee: Meloy Laboratories Inc.. Active years: 1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nava Sarver. Retrieved from https://idiyas.com/inventor/nava-sarver

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nava Sarver: Innovator in Recombinant DNA Technology

Introduction

Nava Sarver is a notable inventor based in Potomac, MD (US). He has made significant contributions to the field of biotechnology, particularly in the production of recombinant proteins.

Latest Patents

Nava Sarver holds a patent for the "Sustained production of recombinant gamma interferon." This patent involves a recombinant DNA expression vector that includes an Epstein-Barr virus origin of replication, an EBNA-1 gene, a selectable marker expression cassette, and a human gamma interferon expression cassette. The invention also describes a mammalian host cell transformed by this vector and a process for producing human gamma interferon using the transformed mammalian host cell.

Career Highlights

Nava Sarver is associated with Meloy Laboratories Inc., where he applies his expertise in recombinant DNA technology. His work has been instrumental in advancing the production of therapeutic proteins.

Collaborations

Some of his notable coworkers include Janet M. Young and William N. Drohan. Their collaboration has contributed to the innovative research environment at Meloy Laboratories Inc.

Conclusion

Nava Sarver's work in recombinant DNA technology exemplifies the impact of innovation in biotechnology. His contributions continue to influence the field and pave the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…